LIS Buyer's Guide — How to Evaluate, RFP, and Choose a Modern Laboratory Information System

Quick answer: An LIS buyer’s guide is a structured evaluation framework lab directors and IT teams use during vendor selection — covering accessioning, instrument integration, HL7/EMR connectivity, QC, autoverification, billing, portals, security, and validated change control. Helps narrow the field around CLIA/CAP-defensible requirements before issuing a formal RFP.

Most laboratories evaluating a new LIS face the same problem: a dozen vendors, glossy demos, RFP responses that all claim every feature, and a procurement timeline that has to land somewhere between operational urgency and capital cycle. This guide is built to cut through that — what to evaluate, what questions to ask, how to compare cloud and on-prem options, and how to structure an RFP that produces a defensible decision rather than a vendor-led one. Use it as a working checklist, not a sales document.

What to evaluate

Score each category on a 1–5 depth scale. A LIS that hits 5/5 on workflow fit and 2/5 on integrations will burn the lab; a LIS that hits 5/5 on integrations and 2/5 on QC will burn the pathologists. The categories that actually move the needle:

• Clinical workflow fit — accessioning by barcode and requisition, ORM intake, ORU release, manual and reflex testing, microbiology workups, anatomic pathology, point-of-care reconciliation, and the specific bench gestures your techs make every day.
• Instrument and EMR integration depth — bidirectional analyzer interfaces (chemistry, hematology, immunology, molecular, mass spec, sequencers); EMR/EHR connectivity over HL7 v2 (ORM, ORU, ADT) and FHIR; reference-lab routing.
• HL7 v2 and FHIR support — which segments, which message types, who builds and validates interfaces, how are version mismatches handled, what does ongoing change cost.
• Autoverification and QC — configurable rules-based resulting with full override audit, plus Levey-Jennings, Westgard multi-rule, control-lot handling, and corrective action tracking — see QC software.
• Billing and revenue cycle integration — clean ICD/CPT coding, payer rules, claim handoff, denial loop, and the ability to plug into existing RCM rather than forcing a swap.
• Multi-site and tenant isolation — can the platform run distinct sites, distinct catalogs, and distinct security boundaries on one tenant, and what does cross-site reporting look like.
• Role-based access and audit trail — defensible permissions, electronic signature, and immutable audit suitable for CAP and CLIA inspections.
• Security and compliance posture — capability support for HIPAA, CAP, and CLIA controls; data encryption in transit and at rest; documented change control. Labs are certified, not software, but the LIS has to support the controls inspectors expect to see. The cloud LIS security architecture guide breaks down what a HIPAA-aligned cloud LIS looks like across administrative, physical, and technical safeguards — useful as a vendor-questionnaire backbone.
• Scalability — peak accession volume, concurrent users, interface throughput, and the headroom to absorb 2–3x growth without re-platforming.
• Vendor support model — support hours, escalation path, named contacts, response and resolution targets, and how releases are validated.
• Training and change management — role-based curriculum for accessioners, techs, pathologists, supervisors, and ordering clinicians.
• Legacy data migration — how much history moves, in what fidelity, who maps the legacy schema, and how the migration is validated before go-live. See the section below.
• Total cost of ownership — three-year view across subscription, interfaces, training, change orders, and internal time.

How to score and compare vendors

The categories above are not equal — weight them before you score. A high-complexity molecular or toxicology lab should weight instrument integration, autoverification, and specialty depth well above portal polish; a physician office lab inverts several of those. Assign each category a weight that reflects how badly a 2/5 result there would hurt daily operations, then score every shortlisted vendor 1–5 on depth — not presence, since most platforms claim every feature — and multiply weight by score.

A workable starting weighting, tuned to your lab’s mix:

Sum the weighted scores per vendor and compare totals, but treat any category scoring 2/5 or below as a veto flag regardless of the aggregate — a strong total can hide a single gap that forces the lab to spreadsheet around the LIS. Score every vendor against the same rubric, ideally with the same reviewers watching the same scripted demo against your real specimens, so the decision stays defensible when procurement or the medical director asks how it was reached.

Cloud LIS vs on-prem LIS — quick decision criteria

For most clinical and specialty labs, cloud is the default. See the cloud LIS software guide for the longer overview and the cloud LIS vs on-premise comparison for the full decision framework — TCO, security, integrations, and migration.

Module checklist by lab type

Different lab types stress different parts of the platform. Use this as a starting point for your RFP.

• Clinical / hospital outreach — accessioning, ORM/ORU, autoverification, QC, microbiology, AP, billing handoff, client and patient portals.
• Toxicology — chain of custody, confirmation testing, MRO workflow, provider portal, ELR for reportable substances; see toxicology cloud LIS and the presumptive-to-LC-MS/MS reflex guide for how the screen-then-confirm cascade is automated.
• Molecular — plate and well tracking, amplicon and aliquot lineage, reagent lot capture, NGS run management; see molecular cloud LIS.
• Public health — ELR to state and federal systems, reportable disease workflow, surge capacity, surveillance reporting; see public health LIMS.
• Physician office labs (POL) — light accessioning, ordering provider portal, simplified billing, fast onboarding; see physician office lab LIS.
• Specialty labs — chemistry, hematology, immunology, serology, FISH, cytology, microbiology, and NGS — depth in the modules your bench actually runs.

If your platform forces you to spreadsheet around a missing module, you have not selected a LIS — you have selected the start of a custom build.

Legacy data migration and historical results

Legacy data migration is the process of moving a lab’s existing patient, provider, catalog, and result records out of the outgoing system and into the new LIS in a validated, queryable form. It is the evaluation dimension buyers most often defer to implementation, and the one most likely to blow up a timeline — the legacy schema is rarely documented, the outgoing vendor rarely helps, and the scope is usually settled after the contract is signed rather than during the RFP.

Decide scope before you shortlist. Retention is the floor: CLIA sets minimum record-retention periods under 42 CFR Part 493 — §493.1105 requires test requisitions and result reports be kept at least two years, with longer holds for pathology and blood-bank records — and state law and CAP checklists frequently require more. Migrate to that floor plus whatever the bench actually uses for delta checks and cumulative reporting; archive the rest rather than paying to convert it.

What to settle with each vendor before the contract:

• Scope by record class — patient and provider master, test and reflex catalog, client and payer setup, QC history, control lots, and how many years of discrete results.
• Fidelity — discrete coded fields versus flat PDF images. Only discrete data supports delta checks, cumulative reports, and trending; PDFs satisfy retention and nothing else.
• Coded vocabulary mapping — how legacy local codes map to LOINC, SNOMED CT, CPT, and ICD-10 in the new catalog, and who owns the crosswalk.
• Ownership and effort — who extracts from the legacy system, who maps the schema, who reconciles exceptions, and how those hours are billed.
• Validation — record counts, field-level spot checks against source, and a signed reconciliation report before go-live, folded into the LIS validation package rather than run as an informal check.
• Archive strategy — read-only access to unmigrated history, how long the legacy contract must stay live, and what that parallel period costs.
• Cutover mechanics — the freeze window, how in-flight specimens accessioned in the old system are resulted in the new one, and the rollback plan.

Ask for the migration approach in writing during the RFP, not after selection. A vendor that cannot describe how it mapped a comparable lab’s legacy result history is telling you the work will land on your team. LIMS IQ handles data migration from legacy systems as part of onboarding; the scope conversation still belongs in the RFP, so both sides size it against the same record classes.

Selection red flags

Most failed LIS selections fail the same handful of ways. Treat each of the following as a reason to slow down, not necessarily to disqualify:

1. The demo never touched your data. A generic walkthrough on the vendor’s sample database proves nothing. Insist on a scripted demo against your specimens, your instruments, your EMR message samples, and your report templates.
2. Feature presence is scored instead of feature depth. Every platform claims autoverification, QC, and HL7. Score 1–5 on how deep each goes, and make the vendor demonstrate the depth rather than assert it.
3. The bench is not in the room. Evaluations run entirely by IT and administration select systems techs then work around. Put accessioners, techs, and supervisors on the scoring panel.
4. Interfaces and training are treated as line items. Together they routinely equal or exceed first-year subscription. A quote that prices them vaguely is a quote that will be revised.
5. References are vendor-curated only. Ask for labs matching your volume, specialty mix, and integration footprint, and ask to speak with a supervisor or bench tech rather than only the executive sponsor.
6. Exit terms are unread. Data-export scope, format, and timeline at contract end decide whether you can ever leave. Settle them before signing, when you still have leverage.
7. A promised go-live date with no validation plan. A calendar commitment that has no named IQ/OQ/PQ work, owners, evidence, and readiness gates moves the risk to your inspection rather than controlling it in the project.
8. No named owner for interface maintenance. “We’ll work it out” means the lab owns it. Get vendor, lab, and third-party responsibilities written down per interface.

Implementation and timeline expectations

Plan an LIS implementation around readiness gates rather than a universal week range. LIMS IQ Lite uses a short, checklist-driven onboarding path for a standardized single-site workflow. LIMS IQ is scoped separately because test-catalog complexity, instrument and HL7 interface count, migration scope, sites, validation depth, training, and partner readiness determine the schedule. Both editions move through defined phases for discovery, configuration, interface build, validation, training, go-live, and support handoff.

Ask every vendor to connect its proposed dates to scope, dependencies, owners, evidence, and exit criteria. A short schedule without a clear validation plan is not credible, and a long schedule without named complexity drivers is not informative. See the LIS implementation timeline guide for a phase-by-phase breakdown and the deliverables to expect at each gate.

Pricing models you’ll encounter

LIS pricing is rarely apples-to-apples. The common shapes:

• Per-user subscription — predictable for stable headcount, painful when volume per user is uneven.
• Per-requisition or per-accession — scales with volume, aligns vendor and lab incentives, harder to forecast in fast-growth phases.
• Tiered subscription — fixed monthly band based on volume, modules, sites, or interfaces; most predictable for budgeting.
• License plus maintenance (on-prem) — large upfront capital plus annual maintenance; rare in modern cloud deals.

Implementation, interface build, training, and ongoing change orders are usually billed separately under any pricing model. Ask for a sample SOW from a comparable lab, not just a price sheet. See LIMS IQ pricing for LIMS IQ Lite and the full LIMS IQ platform.

Questions to ask every vendor in your RFP

A focused RFP outperforms a 200-question template. The questions below cover the areas where vendors differ most:

1. Which HL7 v2 segments and message types do you support out of the box, and which require custom work? Bidirectional?
2. Do you support FHIR endpoints today? Which resources?
3. Walk through your autoverification rule engine. How complex can a rule be, and how is every override audited?
4. Show your QC module — Levey-Jennings, Westgard multi-rule, control lots, corrective actions, and CAP-ready exports.
5. What validation package do you deliver — IQ, OQ, PQ — and who executes each?
6. Do you support ELR to state public health systems for reportable diseases?
7. What is your published uptime SLA and your downtime procedure? How are scheduled maintenance windows handled?
8. What are the data export terms at contract end? Format, scope, and timeline.
9. Who builds and maintains EMR and instrument interfaces — the vendor, the lab, or a third party?
10. What is your support model — hours, escalation, named contact, response and resolution targets?
11. How are releases validated? Who signs off on regression for clinical workflows?
12. What does a typical change request cost and how long does it take?
13. Provide three references with similar specialty mix, volume, and integration footprint.
14. Provide a sample SOW from a comparable implementation.
15. Total three-year cost across subscription, implementation, interfaces, training, and expected change orders.
16. How do you migrate legacy data — which record classes, how many years of discrete results, who maps the legacy schema, and how is the migration validated and signed off before go-live?
17. How are legacy local test codes mapped to LOINC, SNOMED CT, CPT, and ICD-10 in the new catalog, and who owns that crosswalk?

Where LIMS IQ fits

LIMS IQ is a cloud LIS purpose-built for clinical and specialty laboratories — engineered around the depth high-complexity labs need, with the operational footprint of a managed service.

• Clinical core — accessioning, specimen tracking, instrument interfaces, HL7 / FHIR integration, rules-based autoverification, QC, reporting, billing handoff.
• Specialty depth — toxicology, molecular, NGS, FISH, cytology, microbiology, hematology, chemistry, immunology, serology, and public-health workflows on one platform.
• Portals — client portal for ordering providers; patient portal for direct-to-consumer and outreach work.
• Analytics — operational and clinical lab analytics dashboards across volume, turnaround, QC, and revenue.
• Product paths — LIMS IQ Lite for fast standup at smaller and physician-office labs, and the full LIMS IQ platform for high-complexity and multi-site operations.
• Implementation — Lite follows a short, checklist-driven onboarding path; Full-platform LIMS IQ uses phased onboarding scoped to the lab’s catalog, interfaces, migration, sites, validation, training, and partner readiness. See the implementation timeline.
• Compliance posture — HIPAA, CAP, and CLIA-aligned controls with role-based access, audit trail, and electronic signature.

Related reading

• LIS vs LIMS — Clinical vs research / specialty
• LIS vs EMR — How they differ and connect
• LIS implementation timeline
• LIS validation — IQ, OQ, PQ for clinical labs
• LIS glossary — Clinical lab informatics terms
• Integrations hub

Ready to RFP?

If LIMS IQ is on your shortlist, we will run a scripted demo against your actual workflows — your specimens, your instruments, your EMR, and your reporting templates — rather than a generic walkthrough. Request a demo and we will tailor the session to your lab’s mix, or contact the team to walk through your RFP requirements directly.